Online citations, reference lists, and bibliographies.
← Back to Search

"Nanoantibiotics": A New Paradigm For Treating Infectious Diseases Using Nanomaterials In The Antibiotics Resistant Era.

Ae Jung Huh, Y. J. Kwon
Published 2011 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Despite the fact that we live in an era of advanced and innovative technologies for elucidating underlying mechanisms of diseases and molecularly designing new drugs, infectious diseases continue to be one of the greatest health challenges worldwide. The main drawbacks for conventional antimicrobial agents are the development of multiple drug resistance and adverse side effects. Drug resistance enforces high dose administration of antibiotics, often generating intolerable toxicity, development of new antibiotics, and requests for significant economic, labor, and time investments. Recently, nontraditional antibiotic agents have been of tremendous interest in overcoming resistance that is developed by several pathogenic microorganisms against most of the commonly used antibiotics. Especially, several classes of antimicrobial nanoparticles (NPs) and nanosized carriers for antibiotics delivery have proven their effectiveness for treating infectious diseases, including antibiotics resistant ones, in vitro as well as in animal models. This review summarizes emerging efforts in combating against infectious diseases, particularly using antimicrobial NPs and antibiotics delivery systems as new tools to tackle the current challenges in treating infectious diseases.
This paper references
10.1586/14760584.6.5.797
Nanoparticles and microparticles as vaccine-delivery systems
M. Singh (2007)
10.1016/j.taap.2007.12.010
Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells.
J. Roberts (2008)
10.1093/JN/133.12.4077
Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli.
M. Roselli (2003)
10.1007/s11671-010-9627-9
Modifying of Cotton Fabric Surface with Nano-ZnO Multilayer Films by Layer-by-Layer Deposition Method
Ş. Uğur (2010)
金触媒化蒸気-液体-固体モードを経て[311]B基板上で横方向に成長した オリエンテーションを備えた平行配向GaAsナノワイヤ
Zhang Guoqiang (2010)
10.1093/JAC/DKM006
The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?
I. Chopra (2007)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
Grijpma, A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis, Acta Orthop
D. Neut (2009)
10.1016/S0167-7799(98)01220-7
Novel applications of liposomes.
D. Lasic (1998)
10.1046/j.1365-2672.2000.01127.x
Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram‐negative bacilli
T. Hamouda (2000)
10.1016/j.mib.2009.12.001
Polymeric particles in vaccine delivery.
A. Rice-Ficht (2010)
10.1016/j.nano.2009.07.001
Nanodelivery in airway diseases: challenges and therapeutic applications.
I. Roy (2010)
10.1016/S0378-5173(02)00080-7
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.
R. Cavalli (2002)
10.1016/J.IJPHARM.2005.01.017
Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels.
M. Qiao (2005)
10.2174/138161206779026245
Polymeric micelles for drug delivery.
S. Croy (2006)
10.1046/j.1365-2672.2001.01291.x
Antimicrobial effect of acidified nitrite on dermatophyte fungi, Candida and bacterial skin pathogens
R. Weller (2001)
10.1080/10611860310001647771
Receptor Mediated Targeting of Lectin Conjugated Gliadin Nanoparticles in the Treatment of Helicobacter pylori
R. Umamaheshwari (2003)
10.1021/JF061310P
Chitosan derivatives killed bacteria by disrupting the outer and inner membrane.
J. Je (2006)
10.1211/jpp.59.8.0002
Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in‐vitro characterization, ex‐vivo and in‐vivo studies
V. Sanna (2007)
10.1016/S0378-5173(99)00448-2
Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
S. Prior (2000)
10.1016/J.EJMECH.2006.12.035
Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.
Y. Cheng (2007)
10.1373/CLINCHEM.2007.090795
Applications of nanobiotechnology in clinical diagnostics.
K. Jain (2007)
10.1155/2009/754810
On the Toxicity of Therapeutically Used Nanoparticles: An Overview
A. El-Ansary (2009)
10.1159/000074060
Toxicity and Antimicrobial Activity of a Hydrocolloid Dressing Containing Silver Particles in an ex vivo Model of Cutaneous Infection
M. Schaller (2003)
10.1021/nl034396z
Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities
Hongwei Gu (2003)
10.2147/IJN.S4937
Nanomedicine in pulmonary delivery
H. M. Mansour (2009)
10.1016/j.biomaterials.2009.01.052
Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles.
Evan M. Hetrick (2009)
10.1016/S0960-8524(03)00002-6
Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens.
Y. Chung (2003)
10.1016/S0169-409X(00)00103-4
Microemulsion-based media as novel drug delivery systems
M. J. Lawrence (2000)
10.1073/pnas.0711714105
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
F. Gu (2008)
10.1164/RCCM.200504-613PP
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
S. Gelperina (2005)
fi zg fi nes , Chemotherapentic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice
D. A. Ashtekar (1993)
, Killing Mechanism Reaction : toward an Understanding of Its 2 Bactericidal Activity of Photocatalytic TiO
P. Maness (1999)
10.4265/BIO.14.69
Antimicrobial activity of fullerenes and their hydroxylated derivatives.
Hisae Aoshima (2009)
10.1016/S1359-6446(02)02498-4
New ways to treat bacterial infections.
P. Taylor (2002)
Schoen fi sch , Antibio fi lm ef fi cacy of nitric oxidereleasing silica nanoparticles
J. K. Shin (2009)
10.1371/journal.pone.0003253
Rapid Nanoparticle-Mediated Monitoring of Bacterial Metabolic Activity and Assessment of Antimicrobial Susceptibility in Blood with Magnetic Relaxation
C. Kaittanis (2008)
10.3109/17453670903350040
A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis
D. Neut (2009)
In vitro activities of a novel nanoemulsion against Burkholderia and other multidrugresistant cystic fi brosisassociated bacterial species , Antimicrob
S. Rathinavelu J. J. LiPuma (2009)
10.1016/S0008-6223(02)00246-4
Evaluation of the anti-microbial properties of an activated carbon fibre supporting silver using a dynamic method
H. Pape (2002)
10.1016/J.BIOMATERIALS.2006.09.047
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
J. Cheng (2007)
10.1007/BF00130002
Intravitreal liposome-encapsulated drugs: A preliminary human report
G. Peyman (2004)
10.1016/J.WATRES.2006.09.018
Hydroxyapatite-supported Ag-TiO2 as Escherichia coli disinfection photocatalyst.
M. Pratap Reddy (2007)
10.1088/0957-4484/21/28/285103
Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation.
X. He (2010)
10.1073/PNAS.87.15.5744
Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
K. Maruyama (1990)
10.1093/JAC/48.3.333
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.
R. Schiffelers (2001)
10.1016/B978-0-12-384931-1.00018-0
R
J. Lackie (2013)
10.1002/med.20140
Nanoparticle formulations in pulmonary drug delivery
Mark M. Bailey (2009)
Microemulsions are membraneactive , antimicrobial , selfpreserving systems
E. Khalil I. S. Al-Adham (1999)
10.1016/j.nano.2010.04.003
Inorganic nanomedicine--part 2.
B. S. Sekhon (2010)
10.1128/AAC.46.8.2668-2670.2002
Chemiosmotic Mechanism of Antimicrobial Activity of Ag+ in Vibrio cholerae
P. Dibrov (2002)
10.1016/j.tiv.2008.08.009
The effects of nanoparticles on mouse testis Leydig cells in vitro.
T. Komatsu (2008)
10.1093/TOXSCI/KFM243
Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles.
G. Baker (2008)
10.1038/jid.2009.95
Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection.
L. Martinez (2009)
10.1016/j.actbio.2009.09.011
Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis.
W. Jia (2010)
10.1016/S0090-3671(10)79814-1
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America
T. Pruett (2010)
10.1016/j.addr.2007.05.017
Nanotechnology in vaccine delivery☆
Laura J. Peek (2008)
10.1016/0005-2736(89)90078-3
Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues.
T. Allen (1989)
10.1016/j.nano.2009.01.002
Antimicrobial sensitivity of Escherichia coli to alumina nanoparticles.
I. Sadiq (2009)
10.1016/J.BMCL.2006.09.098
Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents.
E. Turos (2007)
10.1529/BIOPHYSJ.105.061895
Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles.
V. Zharov (2006)
10.1007/S11051-005-9001-5
Biodistribution and tumor uptake of C60(OH)x in mice
Z. Ji (2006)
Gasco , Transmucosal transport of tobramyin incorporated in solid lipid nanoparticles ( SLN ) after duodenal administration to rats
R. Cavalli A. Bargoni (2005)
10.1099/00222615-36-1-4
Antibiotic resistance in bacteria.
S. Amyes (1992)
10.1016/j.taap.2008.06.026
Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity.
Ronghui Lei (2008)
10.1111/j.1365-2672.2009.04303.x
Antibacterial activities of zinc oxide nanoparticles against Escherichia coli O157:H7
Y. Liu (2009)
10.1163/156856205774576718
Preparation and antibacterial test of chitosan/PAA/PEGDA bi-layer composite membranes
T. Don (2005)
10.1111/j.1468-2494.2008.00433.x
Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®)
E. B. Souto (2008)
10.1128/AAC.37.11.2293
Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis.
M. Magallanes (1993)
10.1016/j.ijpharm.2007.11.035
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
M. Alipour (2008)
10.1021/la802769m
Inactivation of bacterial pathogens by carbon nanotubes in suspensions.
L. Arias (2009)
10.1016/j.trstmh.2007.07.003
Potential impact of nanotechnology on the control of infectious diseases
R. Allaker (2008)
10.1016/J.WATRES.2006.07.006
A practical demonstration of water disinfection using TiO2 films and sunlight.
Silvia Gelover (2006)
10.1515/9783111576855-015
J
Seguin Hen (1824)
10.1136/BMJ.S1-14.13.342
Case of Uterine Polypus Coexisting with Pregnancy and Spontaneous Expulsion of the Tumour.
W. Hl (1850)
10.1016/j.cis.2008.09.002
Silver nanoparticles: green synthesis and their antimicrobial activities.
V. Sharma (2009)
10.1016/J.IJBIOMAC.2006.02.023
The development of rapid fluorescence-based immunoassays, using quantum dot-labelled antibodies for the detection of Listeria monocytogenes cell surface proteins.
E. Tully (2006)
10.1081/LPR-200029887
The Delivery of Benzyl Penicillin to Staphylococcus aureus Biofilms by Use of Liposomes
H. Kim (2004)
10.1002/LSM.20534
Photothermal antimicrobial nanotherapy and nanodiagnostics with self‐assembling carbon nanotube clusters
Jin-Woo Kim (2007)
10.1021/LA053293O
Characterizing the impact of preparation method on fullerene cluster structure and chemistry.
J. Brant (2006)
10.1002/smll.200700863
A single-walled-carbon-nanotube filter for removal of viral and bacterial pathogens.
Anna S Brady-Estévez (2008)
Inactivation of nanocrystalline C60 cytotoxicity by gamma-irradiation.
A. Isakovic (2006)
10.1002/JBM.B.30994
Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery.
D. Jain (2008)
10.1371/journal.pone.0002954
Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
P. Makidon (2008)
10.1093/JAC/DKH478
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?
F. Furno (2004)
10.1016/j.marenvres.2009.07.001
An investigation into the effects of silver nanoparticles on antibiotic resistance of naturally occurring bacteria in an estuarine sediment.
M. Mühling (2009)
10.1128/AAC.33.9.1540
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles.
E. Fattal (1989)
10.1006/PHRS.2001.0813
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution.
A. Bargoni (2001)
Schoen fi sch , Bactericidal ef fi cacy of nitric oxidereleasing silica nanoparticles
A. C. Hunter (2008)
Mechanism of enhanced activity of liposomeentrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa , Antimicrob
M. Halwani C. Mugabe (2008)
10.1021/NL048774R
Morphological Control of Room-Temperature Ionic Liquid Templated Mesoporous Silica Nanoparticles for Controlled Release of Antibacterial Agents
B. Trewyn (2004)
10.1021/la902844r
A multifunctional biocide/sporocide and photocatalyst based on titanium dioxide (TiO2) codoped with silver, carbon, and sulfur.
Dambar B. Hamal (2010)
10.1128/aem.02218-06
Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli
S. Pal (2007)
10.1063/1.2742324
Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems.
K. M. Reddy (2007)
10.1021/NL051866B
[60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity.
N. Gharbi (2005)
10.1021/nn700191f
Bactericidal efficacy of nitric oxide-releasing silica nanoparticles.
Evan M. Hetrick (2008)
Liposome - incorporated cipro fl oxacin in treatment of murine salmonellosis , Antimicrob
J. Dijkstra M. Magallanes (2004)
10.1152/AJPLUNG.00478.2001
In vivo and in vitro uptake of surfactant lipids by alveolar type II cells and macrophages.
D. Poelma (2002)
10.1111/j.1365-2672.2009.04594.x
Antimicrobial efficiency of titanium dioxide‐coated surfaces
P. Murányi (2010)
10.2165/00003495-200059060-00003
Carrier Systems for the Local Delivery of Antibiotics in Bone Infections
K. Kanellakopoulou (2012)
10.1128/AAC.00346-09
VanA-Type Vancomycin-Resistant Staphylococcus aureus
B. Périchon (2009)
10.1016/b978-0-12-384931-1.00003-9
C
J. Lackie (2013)
10.1002/ADFM.200600390
Hierarchical shelled ZnO structures made of bunched nanowire arrays
P. Jiang (2007)
10.4014/JMB.0904.04038
In vitro screening for anti-microbial activity of chitosans and chitooligosaccharides, aiming at potential uses in functional textiles.
J. Fernandes (2010)
Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether.
D. Bhadra (2005)
Preparation , characterization and in vitro antimicrobiral activity of ampicillinloaded polyethylcyanoacrylate nanoparticles
M. Licciardi G. Fontana (1998)
10.1080/1061186021000060738
In Vitro Antileishmanial Activity of Amphotericin B Loaded in Poly(ε-Caprolactone) Nanospheres
M. S. Espuelas (2002)
10.1007/s11046-008-9109-0
Update in Antifungal Therapy of Dermatophytosis
A. Gupta (2008)
10.1038/2151016a0
One Step On
안경승 (1967)
10.1021/BM034130M
Chitosan as antimicrobial agent: applications and mode of action.
E. Rabea (2003)
10.1016/0022-4804(90)90258-4
Topical liposomal delivery of antibiotics in soft tissue infection.
C. Price (1990)
10.4315/0362-028X-69.12.2947
Inhibition and inactivation of Listeria monocytogenes and Escherichia coli O157:H7 colony biofilms by micellar-encapsulated eugenol and carvacrol.
D. Pérez-Conesa (2006)
10.1093/TOXSCI/KFI256
In vitro cytotoxicity of nanoparticles in mammalian germline stem cells.
L. Braydich-Stolle (2005)
10.1016/J.NANO.2007.02.001
Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli.
A. Shahverdi (2007)
10.1021/LA052797J
Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding.
R. Bagwe (2006)
10.1016/j.taap.2009.09.021
Phototoxicity and cytotoxicity of fullerol in human retinal pigment epithelial cells.
A. Wielgus (2010)
10.1016/J.NANO.2005.10.003
Nanomedicine and nanotoxicology: two sides of the same coin.
V. Kagan (2005)
10.1371/journal.pone.0007072
Prodepth: Predict Residue Depth by Support Vector Regression Approach from Protein Sequences Only
Jiangning Song (2009)
10.1021/NL062553Z
One-step, nanoparticle-mediated bacterial detection with magnetic relaxation.
C. Kaittanis (2007)
10.1039/b715532h
The use of nanoparticles in anti-microbial materials and their characterization.
E. Weir (2008)
10.1002/ADMA.200600200
Dissolving Behavior and Stability of ZnO Wires in Biofluids: A Study on Biodegradability and Biocompatibility of ZnO Nanostructures
J. Zhou (2006)
10.1016/J.BIOMATERIALS.2007.09.002
The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes.
Z. Markovic (2007)
10.1002/CHIN.200528279
Nanostructures in Biodiagnostics
N. Rosi (2005)
10.1016/j.ijpharm.2010.04.026
Potential neurotoxicity of nanoparticles.
Yu-Lan Hu (2010)
10.1007/s10719-004-5539-1
Nano-biosensor development for bacterial detection during human kidney infection: Use of glycoconjugate-specific antibody-bound gold NanoWire arrays (GNWA)
Manju Basu (2004)
10.1016/j.biomaterials.2009.07.033
The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.
Darren Yang (2009)
10.1016/j.ijfoodmicro.2009.04.013
Oleoyl-chitosan nanoparticles inhibits Escherichia coli and Staphylococcus aureus by damaging the cell membrane and putative binding to extracellular or intracellular targets.
Ke Xing (2009)
10.1093/JAC/37.1.105
Intracellular distribution of ampicillin in murine macrophages infected with Salmonella typhimurium and treated with (3H)ampicillin-loaded nanoparticles.
O. Balland (1996)
10.3109/10611869609015975
Encapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis.
Neil M. Sanderson (1996)
10.1128/IAI.00070-07
Mucosal Immunization with a Novel Nanoemulsion-Based Recombinant Anthrax Protective Antigen Vaccine Protects against Bacillus anthracis Spore Challenge
A. Bielinska (2007)
10.1016/J.BIOMATERIALS.2006.05.047
Inactivation of nanocrystalline C60 cytotoxicity by γ-irradiation
A. Isakovic (2006)
10.1016/J.NANO.2006.12.001
Antimicrobial effects of silver nanoparticles.
J. Kim (2007)
10.1021/nl0726398
Antibacterial activity of fullerene water suspensions (nC60) is not due to ROS-mediated damage.
D. Lyon (2008)
10.1080/02652040500162436
SLN and NLC for topical delivery of ketoconazole
E. Souto (2005)
10.1007/BF00381789
Energy-dispersive X-ray analysis of the extracellular cadmium sulfide crystallites of Klebsiella aerogenes
J. Holmes (2004)
10.1289/ehp.7339
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
G. Oberdörster (2005)
10.1186/1745-6673-2-16
Nanotechnology-based drug delivery systems
S. Suri (2007)
10.1056/NEJM199611073351907
Antimicrobial-drug resistance.
H. Gold (1996)
10.1016/J.IJFOODMICRO.2007.05.008
Antimicrobial effects of a microemulsion and a nanoemulsion on enteric and other pathogens and biofilms.
P. Teixeira (2007)
10.1002/CHIN.200528276
Nanoparticles in Energy Technology: Examples from Electrochemistry and Catalysis
F. Raimondi (2005)
10.1016/j.colsurfb.2008.09.022
Extracellular biosynthesis of functionalized silver nanoparticles by strains of Cladosporium cladosporioides fungus.
D. S. Balaji (2009)
10.1080/1061186021000054933
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
M. Videira (2002)
10.1016/j.biomaterials.2009.03.044
The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies.
Khadijah M. Hindi (2009)
10.1016/J.JCIS.2004.02.012
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria.
I. Sondi (2004)
10.1016/S0305-4179(99)00108-4
Historical review of the use of silver in the treatment of burns. I. Early uses.
H. Klasen (2000)
10.1002/JBM.A.30766
In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment.
J. Koort (2006)
10.1016/S0045-6535(03)00362-X
Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light.
K. P. Kühn (2003)
10.1128/AAC.01547-05
Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas aeruginosa
Clement Mugabe (2006)
10.1093/TOXSCI/KFG243
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation.
C. Lam (2004)
10.1002/smll.201002349
A nanochannel/nanoparticle-based filtering and sensing platform for direct detection of a cancer biomarker in blood.
Alfredo de la Escosura-Muñiz (2011)
10.1016/J.NIOX.2006.04.002
The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice.
R. Weller (2006)
10.1016/j.nano.2009.04.006
Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria.
A. M. Fayaz (2010)
10.1016/S1359-6446(04)03276-3
Dendrimers and dendritic polymers in drug delivery.
E. Gillies (2005)
10.1111/j.1469-0691.2009.02738.x
Clinical impact of antibiotic-resistant Gram-positive pathogens.
H. Lode (2009)
10.1038/263797A0
Polymers for the sustained release of proteins and other macromolecules
R. Langer (1976)
10.1021/LA701067R
Single-walled carbon nanotubes exhibit strong antimicrobial activity.
S. Kang (2007)
10.1039/c0nr00329h
Antimicrobial biomaterials based on carbon nanotubes dispersed in poly(lactic-co-glycolic acid).
Seyma Aslan (2010)
10.1021/nn101558x
Electronic-structure-dependent bacterial cytotoxicity of single-walled carbon nanotubes.
C. Vecitis (2010)
10.1016/S0169-409X(02)00053-4
Polyanhydride implant for antibiotic delivery--from the bench to the clinic.
L. Li (2002)
10.1016/j.watres.2010.04.023
Impact of solution chemistry on viral removal by a single-walled carbon nanotube filter.
Anna S Brady-Estévez (2010)
10.1093/JAC/30.2.173
Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages.
F. Forestier (1992)
10.1093/ANNHYG/MEI019
Exposure-related health effects of silver and silver compounds: a review.
P. Drake (2005)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.2174/092986710790416290
Development of nanoparticles for antimicrobial drug delivery.
L. Zhang (2010)
10.1016/j.watres.2008.08.015
Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications.
Q. Li (2008)
10.1016/J.JCONREL.2007.10.011
Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
Wassana Wijagkanalan (2008)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul
W. I. Hagens (2007)
10.1042/BA20090198
Preparation, characterization and evaluation of a biopolymeric gold nanocomposite with antimicrobial activity
M. Chamundeeswari (2010)
10.1088/0957-4484/20/50/505701
Antibacterial and antifungal activity of a soda-lime glass containing copper nanoparticles.
L. Esteban-Tejeda (2009)
10.1093/JAC/28.3.425
Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice.
P. Gangadharam (1991)
10.1136/bmj.d3737
Bean sprouts are identified as cause of E coli outbreak
A. Tuffs (2011)
10.1007/BF01030998
N-carboxymethylchitosan inhibition of aflatoxin production: Role of zinc
R. Cuero (2005)
10.1099/JMM.0.46124-0
Antimicrobial activities of silver dressings: an in vitro comparison.
M. Ip (2006)
10.1023/A:1016318423563
Controlled Release of Polypeptides and Other Macromolecules
R. Siegel (2004)
10.1002/smll.200801042
Multifunctional Fe3O4@Au nanoeggs as photothermal agents for selective killing of nosocomial and antibiotic-resistant bacteria.
Wei-Chieh Huang (2009)
Woodle , Ef fi cacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniaeinfected lung tissue
M. T. ten Kate I. A. Bakker-Woudenberg (1998)
10.1517/17425240802652309
Recent advances in liposomal dry powder formulations: preparation and evaluation.
A. Misra (2009)
10.1002/JBM.B.30374
In vitro and in vivo release of gentamicin from biodegradable discs.
Pavan Kumar Naraharisetti (2006)
10.1201/9781420039207.CH11
Solid Lipid Nanoparticles for Topical Delivery
Zhinan Mei (2005)
Amoxicillinloaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size
G. Fontana (2001)
10.1016/J.BMCL.2003.09.040
Antibacterial and antiproliferative activity of cationic fullerene derivatives.
T. Mashino (2003)
10.1016/j.colsurfb.2010.03.029
A review on the application of inorganic nano-structured materials in the modification of textiles: focus on anti-microbial properties.
R. Dastjerdi (2010)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1016/S0006-2952(02)01346-1
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
Abdelwahab Omri (2002)
10.1016/S0165-2478(03)00176-7
Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles.
P. Johansen (2003)
10.1016/j.actbio.2007.11.006
Strain specificity in antimicrobial activity of silver and copper nanoparticles.
J. Ruparelia (2008)
10.1016/J.IJPHARM.2004.02.032
Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
E. Souto (2004)
10.1073/pnas.0307128101
Detection of bacteria in suspension by using a superconducting quantum interference device
H. L. Grossman (2003)
10.1021/BC049951I
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
10.1016/j.addr.2009.11.011
Application of nanotechnologies for improved immune response against infectious diseases in the developing world.
M. Look (2010)
10.1016/j.biotechadv.2008.09.002
Silver nanoparticles as a new generation of antimicrobials.
M. Rai (2009)
10.1021/ES0603655
Antibacterial activity of fullerene water suspensions: effects of preparation method and particle size.
D. Lyon (2006)
10.2174/157016309787581066
Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.
H. K. Sajja (2009)
10.1016/S0168-3659(00)00208-X
pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery.
M. Risbud (2000)
10.1517/17425247.5.9.931
Drug delivery approaches to overcome bacterial resistance to β-lactam antibiotics
Sampath C Abeylath (2008)
10.1016/j.phymed.2008.06.008
Synergism between natural products and antibiotics against infectious diseases.
S. Hemaiswarya (2008)
10.1021/JS9503690
Liposome-encapsulated ampicillin: physicochemical and antibacterial properties.
I. Schumacher (1997)
10.7150/IJBS.5.153
Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa
S. Tin (2009)
10.1117/1.2793746
Photoacoustic flow cytometry: principle and application for real-time detection of circulating single nanoparticles, pathogens, and contrast dyes in vivo.
V. Zharov (2007)
10.1038/NMAT1192
Carbon nanotube filters
A. Srivastava (2004)
10.1016/S0168-1605(01)00717-6
Antibacterial activity of chitosans and chitosan oligomers with different molecular weights.
H. K. No (2002)
10.1016/j.ejpb.2008.09.023
Dendrimers as versatile platform in drug delivery applications.
S. Svenson (2009)
10.1111/j.1472-8206.2009.00692.x
Emerging trends of nanomedicine – an overview
S. Sandhiya (2009)
10.1016/j.ijantimicag.2008.12.004
Characterisation of copper oxide nanoparticles for antimicrobial applications.
G. Ren (2009)
10.1021/ES061817G
Natural organic matter stabilizes carbon nanotubes in the aqueous phase.
H. Hyung (2007)
10.1093/TOXSCI/KFG228
Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.
D. Warheit (2004)
Of Pseudomonas
D. M. Livermore (2001)
10.1016/S0928-0987(00)00167-6
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
C. Pouton (2000)
10.1016/S0264-410X(03)00381-5
Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.
A. Myc (2003)
10.1016/S0142-9612(97)00246-9
Preparation, characterization and in vitro antimicrobial activity of ampicillin-loaded polyethylcyanoacrylate nanoparticles.
G. Fontana (1998)
10.1039/b809086f
Silver carbonate nanoparticles stabilised over alumina nanoneedles exhibiting potent antibacterial properties.
J. J. Buckley (2008)
10.1126/SCIENCE.297.5586.1536
Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection.
Y. Cao (2002)
10.1046/j.1365-2672.2000.01078.x
Microemulsions are membrane‐active, antimicrobial, self‐preserving systems
I. S. Al-Adham (2000)
10.1038/jid.2009.149
Nitric oxide-containing nanoparticles as an antimicrobial agent and enhancer of wound healing.
R. Weller (2009)
10.1016/J.MATERRESBULL.2007.06.020
Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium semitectum
S. Basavaraja (2008)
Comparison of cipro fl oxacin hydrochlorideloaded protein , lipid , and chitosan nanoparticles for drug delivery
K. Kisich S. Gelperina (2008)
10.1016/j.addr.2009.11.024
Nanotechnology applied to the treatment of malaria.
N. S. Santos-Magalhães (2010)
10.1038/nrmicro1004
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
F. Fang (2004)
10.1002/JPS.1023
Trends and developments in liposome drug delivery systems.
T. Lian (2001)
10.1093/JAC/49.4.641
In vitro action of carboxyfullerene.
N. Tsao (2002)
10.1021/ES048729L
Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene.
G. Jia (2005)
10.1093/JAC/46.2.311
Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin.
K. Kanellakopoulou (2000)
10.1128/AAC.40.3.665
Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.
C. Beaulac (1996)
10.1021/LA0358567
Ciprofloxacin-protected gold nanoparticles.
Renjis T. Tom (2004)
10.1016/S1077-9108(08)70203-2
A Rapid Bioassay for Single Bacterial Cell Quantitation Using Bioconjugated Nanoparticles
M. Bissell (2006)
10.1016/S0142-9612(02)00036-4
Interactions between dendrimer biocides and bacterial membranes.
C. Chen (2002)
10.3109/10408440903453074
A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity
H. Johnston (2010)
10.1016/J.BIOMATERIALS.2005.05.027
Nano-C60 cytotoxicity is due to lipid peroxidation.
C. Sayes (2005)
10.1016/S0168-3659(00)00339-4
Biodegradable polymeric nanoparticles as drug delivery devices.
K. Soppimath (2001)
10.1023/A:1011925132473
Altered Tissue Distribution and Elimination of Amikacin Encapsulated in Unilamellar, Low-Clearance Liposomes (MiKasome®)
R. Fielding (2004)
10.1016/j.ejpb.2008.08.009
Current in vitro methods in nanoparticle risk assessment: limitations and challenges.
A. Kroll (2009)
10.1038/35021219
Molecular mechanisms that confer antibacterial drug resistance
C. Walsh (2000)
10.1016/S0378-5173(02)00684-1
Cosmetic applications for solid lipid nanoparticles (SLN).
S. Wissing (2003)
10.1016/j.addr.2009.11.013
Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.
C. Kaittanis (2010)
10.1016/J.COLSURFA.2006.10.024
Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles- : A brief study
A. Grace (2007)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1016/J.YRTPH.2007.07.006
What do we (need to) know about the kinetic properties of nanoparticles in the body?
W. Hagens (2007)
10.1128/AAC.00691-08
In Vitro Activities of a Novel Nanoemulsion against Burkholderia and Other Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species
J. LiPuma (2008)
10.1016/j.addr.2009.11.023
New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.
A. Sosnik (2010)
10.1513/PATS.200409-049TA
The lungs as a portal of entry for systemic drug delivery.
John S. Patton (2004)
10.1016/j.fm.2008.05.003
Antimicrobial effects of chitosans and chitooligosaccharides, upon Staphylococcus aureus and Escherichia coli, in food model systems.
J. Fernandes (2008)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1289/EHP.6851
Ultrafine particle deposition in subjects with asthma.
D. Chalupa (2004)
Giamarellos - Bourboulis , Carrier systems for the local delivery of antibiotics in
E. J. K. Kanellakopoulou (2000)
10.1016/J.BMC.2007.11.052
Glyconanobiotics: Novel carbohydrated nanoparticle antibiotics for MRSA and Bacillus anthracis.
Sampath C Abeylath (2008)
10.1088/0957-4484/21/10/105103
Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents.
S. P. Chakraborty (2010)
10.1016/J.TOXLET.2006.08.019
The degree and kind of agglomeration affect carbon nanotube cytotoxicity.
P. Wick (2007)
10.1371/journal.pone.0007804
Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection
G. Han (2009)
10.1016/S0142-9612(01)00030-8
Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
G. Fontana (2001)
10.1096/fj.04-2747rev
Nanomedicine: current status and future prospects
S. Moghimi (2005)
10.1016/j.fertnstert.2009.03.094
Effects of fetal exposure to carbon nanoparticles on reproductive function in male offspring.
S. Yoshida (2010)
10.1016/J.JHIN.2005.04.015
Antimicrobial effect of surgical masks coated with nanoparticles.
Y. Li (2006)
10.1016/J.IJPHARM.2005.10.010
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Donald E. Owens (2006)
10.1016/S0140-6736(11)60847-7
Germany reels in the wake of E coli outbreak
R. Hyde (2011)
10.1016/j.tibtech.2009.12.004
Functionalised gold nanoparticles for controlling pathogenic bacteria.
D. Pissuwan (2010)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1016/J.CARRES.2004.09.007
Preparation and antibacterial activity of chitosan nanoparticles.
Lifeng Qi (2004)
10.1002/JBM.B.30604
Photocatalytic antibacterial effect of TiO(2) film formed on Ti and TiAg exposed to Lactobacillus acidophilus.
Jung-Yoon Choi (2007)
10.1089/CDD.1984.1.119
Controlled release of microquantities of macromolecules.
J. Murray (1984)
10.1016/j.jconrel.2007.12.011
Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections.
S. Chono (2008)
10.1016/j.toxlet.2010.05.010
Intrinsic biological property of colloidal fullerene nanoparticles (nC60): lack of lethality after high dose exposure to human epidermal and bacterial cells.
X. Xia (2010)
10.2174/138920208786847962
Toxicogenomics to Improve Comprehension of the Mechanisms Underlying Responses of In Vitro and In Vivo Systems to Nanomaterials: A Review
A. Poma (2008)
10.1016/J.SCITOTENV.2006.11.007
Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles.
Ki-Young Yoon (2007)
10.1002/elps.200900342
Microstructure of microemulsion in MEEKC
Y. Cao (2010)
10.1126/science.321.5887.356
The Bacteria Fight Back
G. Taubes (2008)
10.1016/J.WATRES.2006.08.004
Comparative eco-toxicity of nanoscale TiO2, SiO2, and ZnO water suspensions.
L. K. Adams (2006)
10.1897/04-649R.1
Bacterial cell association and antimicrobial activity of a C60 water suspension.
D. Lyon (2005)
Microemulsions are highly effective antibio fi lm agents , Lett
N. D. Al-Hmoud I. S. Al-Adham (2000)
10.1016/0196-6553(86)90083-0
Changing patterns of infectious disease
Trish Berglund (1986)
10.1038/SJ.JID.5701096
Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation.
M. Mowbray (2008)
Lipid formulations for oral administration of drugs: nonemulsifying
C. W. Pouton (2000)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.1128/JB.00779-06
Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
N. Barraud (2006)
10.1016/j.colsurfb.2010.01.026
Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE.
M. Saravanan (2010)
10.1093/TOXSCI/KFJ127
Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
A. Isakovic (2006)
10.1021/la7035949
Toxicological effect of ZnO nanoparticles based on bacteria.
Z. Huang (2008)
10.1016/S1011-1344(01)00180-4
Sublethal effects of ultraviolet A radiation on Enterobacter cloacae.
O. Oppezzo (2001)
10.1016/j.addr.2012.09.018
Microemulsion-based media as novel drug delivery systems.
M. Lawrence (2000)
10.1021/la901092x
Hydrophobically modified biodegradable poly(ethylene glycol) copolymers that form temperature-responsive Nanogels.
K. Nagahama (2009)
10.1016/J.EJMECH.2006.07.015
Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Minglu Ma (2007)
Emerging Gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences.
S. Arya (2008)
10.1093/JAC/33.3.571
Effect of elimination of phagocytic cells by liposomal dichloromethylene diphosphonate on aspergillosis virulence and toxicity of liposomal amphotericin B in mice.
M. Moonis (1994)
10.1016/j.geb.2003.09.006
Preparation
M. Voorneveld (2004)
10.1016/S0924-8579(99)00121-1
Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
H. Pinto-Alphandary (2000)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
10.1515/9783111438443-006
N
Città DI Torino (1824)
10.1517/17425247.5.6.703
Mannose-targeted systems for the delivery of therapeutics
J. M. Irache (2008)
10.1088/0957-4484/20/8/085103
The antibacterial and antifungal activity of a soda-lime glass containing silver nanoparticles.
L. Esteban-Tejeda (2009)
10.1021/JP0502196
Anatase TiO2 nanocomposites for antimicrobial coatings.
Guifen Fu (2005)
10.1016/J.TUBE.2004.11.003
Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
R. Pandey (2005)
10.1093/INFDIS/171.4.938
Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.
I. A. Bakker-Woudenberg (1995)
10.1111/j.1742-481X.2006.00265.x
Silver dressings: their role in wound management
D. Leaper (2006)
10.1016/j.biomaterials.2010.03.027
Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles.
Kuo-Ti Peng (2010)
10.1007/BF01715542
Enhanced killing of methicillin-resistantStaphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin
C. Onyeji (1994)
10.1046/j.1472-765X.2003.01266.x
Microemulsions are highly effective anti‐biofilm agents
I. S. Al-Adham (2003)
10.1021/ac901199w
Extractive electrospray ionization mass spectrometry toward in situ analysis without sample pretreatment.
M. Li (2009)
10.1016/S0924-8579(02)00021-3
Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci.
I. Bakker-Woudenberg (2002)
10.2174/138955709788681582
A new strategy to destroy antibiotic resistant microorganisms: antimicrobial photodynamic treatment.
T. Maisch (2009)
10.1021/ES062181W
Effect of a fullerene water suspension on bacterial phospholipids and membrane phase behavior.
J. Fang (2007)
10.1016/j.biomaterials.2009.07.037
Antibiofilm activity of nanosized magnesium fluoride.
J. Lellouche (2009)
10.1093/JAC/47.3.247
Of Pseudomonas, porins, pumps and carbapenems.
D. Livermore (2001)
10.1086/315124
A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species.
T. Hamouda (1999)
10.1021/NL052326H
Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium.
R. Brayner (2006)
10.1016/S0167-7012(03)00037-X
Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay.
J. Sawai (2003)
Schoen fi sch , Bactericidal ef fi cacy of nitric oxidereleasing silica nanoparticles
J. H. Shin (2009)
Bactericidal activity of combinations of Silver-Water Dispersion™ with 19 antibiotics against seven microbial strains
A. D. Souza (2006)
10.1016/j.nano.2009.01.012
Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE.
Anima Nanda (2009)
10.1016/J.IJPHARM.2003.07.014
Preparation and characterization of water-soluble pH-sensitive nanocarriers for drug delivery.
M. Dufresne (2004)
10.1016/j.mib.2009.08.001
The clinical consequences of antimicrobial resistance.
L. Rice (2009)
10.1016/b978-0-12-384931-1.00016-7
P
J. Lackie (2013)
10.1016/J.BMCL.2007.03.077
Penicillin-bound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA.
E. Turos (2007)



This paper is referenced by
10.1134/S2075113320020100
Preparation of Hybrid Nanocomposites Based on Nanoscale Cellulose and Magnetic Nanoparticles with Photocatalytic Properties
Olga L Evdokimova (2020)
10.1021/ACS.JPCC.6B08862
Approach to the Assessment of Size-Dependent Thermal Properties of Disperse Solutions: Time-Resolved Photothermal Lensing of Aqueous Pristine Fullerenes C60 and C70
I. Mikheev (2016)
10.21767/2321-547X.1000018
Development and evaluation of gel incorporated with synthesized silver nanoparticle from Ocimum gratissimum for the treatment of acne vulgaris
S. L. Prabu (2017)
Evaluation of Clinical and Antimicrobial Efficacy of Silver Nanoparticles and Tetracycline Films in the Treatment of Periodontal Pockets
Heba A. Shawky (2015)
10.5772/58423
Nanoparticle based Drug Delivery Systems for Treatment of Infectious Diseases
M. Salouti (2014)
10.1016/J.JFOODENG.2015.11.007
Chitosan nanoparticles loaded with 2,5-dihydroxybenzoic acid and protocatechuic acid: Properties and digestion
A. R. Madureira (2016)
10.1016/J.MATTOD.2018.10.041
Breaking resistance to nanoantibiotics by overriding corona-dependent inhibition using a pH-switch
S. Siemer (2019)
10.1039/c9nj06173h
Quaternized polymer-based nanostructures confer antimicrobial efficacy against multidrug-resistant bacteria
Mu-Han Zhao (2020)
10.3390/molecules25092090
Polydopamine Nanosphere with In-Situ Loaded Gentamicin and Its Antimicrobial Activity
Rahila Batul (2020)
10.1016/j.jcis.2020.02.094
Sustainable approach to almond skin mediated synthesis of tunable selenium microstructures for coating cotton fabric to impart specific antibacterial activity.
Priyadarshani S Sadalage (2020)
10.1007/978-981-15-4630-3_6
Modulating Surface Energy and Surface Roughness for Inhibiting Microbial Growth
S. Majhi (2020)
10.1016/j.colsurfb.2019.110388
Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA).
Pavan Walvekar (2019)
10.1016/J.JDDST.2019.05.004
Melatonin loaded lipid enriched chitosan microspheres – Hybrid dressing for moderate exuding wounds
Marieta Duvnjak Romić (2019)
10.1016/j.ijbiomac.2018.04.092
Chitosan-tailored lipidic nanoconstructs of Fusidic acid as promising vehicle for wound infections: An explorative study.
Kanika Thakur (2018)
10.1016/j.jconrel.2016.01.008
Current applications of nanoparticles in infectious diseases.
H. Zazo (2016)
10.1007/s10616-014-9701-8
Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria
Majed M. Masadeh (2014)
10.4028/www.scientific.net/AST.96.9
Facile In Situ Synthesis and Impregnation of Silver Nanoparticles in a Hydrophobic Polymer for Antimicrobial Biomaterials
P. Tran (2014)
10.3109/10837450.2013.846375
Optimization of particle size and encapsulation efficiency of vancomycin nanoparticles by response surface methodology
S. Honary (2014)
10.1016/J.JALLCOM.2014.04.040
Investigations of optical, structural and antibacterial properties of Al–Cr dual-doped ZnO nanostructures
A. H. Shah (2014)
10.1021/nn3008383
Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics.
Aleksandar F. Radovic-Moreno (2012)
10.1016/j.ijpharm.2013.11.038
Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood.
M. Kumar (2014)
10.1007/978-3-319-68424-6_12
Myconanotechnology to Treat Infectious Diseases: A Perspective
E. Castro-Longoria (2017)
10.1016/B978-0-323-42864-4.00010-5
Antifungal nanomaterials: Synthesis, properties, and applications
Farnoush Asghari (2016)
10.1016/B978-0-323-52725-5.00005-8
Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems
Mehmet Gumustas (2017)
10.1016/j.lfs.2017.06.017
Synthesis of biogenic Ag@Pd Core‐shell nanoparticles having anti‐cancer/anti‐microbial functions
W. Abd-el-fattah (2017)
10.3390/pharmaceutics11020057
Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
M. López-López (2019)
10.1186/2008-2231-20-92
Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles
Mona Noori Koopaei (2012)
10.2147/IJN.S140625
Single-walled carbon nanotubes-ciprofloxacin nanoantibiotic: strategy to improve ciprofloxacin antibacterial activity
Mohyeddin Assali (2017)
Isolation and characterisation of antifungal and antibacterial compounds from Combretum molle (Combretaceae) leaf extracts
M. M. Mogashoa (2017)
Lipid-based nanoparticles as novel drug delivery systems for antimicrobial agents
A. Rassouli (2019)
10.1515/ntrev-2017-0159
Copper nanoparticles as an alternative feed additive in poultry diet: a review
A. Scott (2017)
In vitro assessment of Ag 2 O nanoparticles toxicity against Gram-positive and Gram-negative bacteria
Harshita Negi (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar